Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/26 16:39 | 4/1/26 | TRDA | Health | Drug | Pharmaceutical Preparations | Wentworth Kory James | MA | O | CFO | 6 | S.dm | -573 | 13.11 | 0 | -44 | 138 | D | |||||||||||||||
3/11/26 16:35 | 3/9/26 | TRDA | Health | Drug | Pharmaceutical Preparations | Dowden Nathan J | MA | O | P,COO | 1 | S.m | -196 | 13.04 | 0 | -15 | 199 | D | |||||||||||||||
11/18/25 16:36 | 11/14/25 | TRDA | Health | Drug | Pharmaceutical Preparations | Parmar Kush | CA | DT | 3 | S.m | -2,829 | 8.04 | 0 | -352 | 4,283 | I | ||||||||||||||||
11/18/25 16:34 | 7/9/25 | TRDA | Health | Drug | Pharmaceutical Preparations | 5Am Ventures V, L.P. | CA | T | 3 | S.m | -2,829 | 8.04 | 0 | -352 | 4,283 | M | ||||||||||||||||
12/12/24 17:00 | 12/10/24 | TRDA | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures 2018, L.P. | MA | T | 1 | S.m | -917 | 20.51 | 0 | -45 | 4,381 | I | ||||||||||||||||
12/12/24 17:00 | 12/10/24 | TRDA | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures 2014, L.P. | MA | T | 1 | S.m | -917 | 20.51 | 0 | -45 | 4,381 | I | ||||||||||||||||
12/3/24 17:24 | 11/29/24 | TRDA | Health | Drug | Pharmaceutical Preparations | Sethuraman Natarajan | MA | O | P,Resear | 1 | S.m | -321 | 20.18 | 0 | -16 | 145 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |